Home›Research›Compare›BPC-157 vs Leu-Enkephalin
Peptide Comparison
BPC-157 vs Leu-Enkephalin
Both are Recovery peptides.
BPC-157
Body Protection Compound 157
Half-life: 4–6 hours (subcutaneous); 1–2 hours (oral)
603 providers listed
Leu-Enkephalin
Leucine enkephalin
No providers listed yet
Quick Verdict
BPC-157
Risk
Half-life
4–6 hours (subcutaneous); 1–2 hours (oral)
Leu-Enkephalin
Risk
Half-life
—
Side-by-Side Comparison
Research Quality
BPC-157
Leu-Enkephalin
About BPC-157
BPC-157 is believed to accelerate angiogenesis and upregulate growth hormone receptors locally at injury sites. It appears to promote fibroblast migration and collagen synthesis, contributing to faster tissue remodelling. Animal studies suggest systemic effects via modulation of the dopaminergic and serotonergic systems, though human data remain limited.
Research Areas
About Leu-Enkephalin
Binds delta and mu opioid receptors in the CNS and periphery. Modulates pain signal transmission in dorsal horn neurons. Also activates opioid receptors on immune cells, influencing cytokine production and immune cell trafficking.
Research Areas
Safety Profile
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
BPC-157
Contraindications
Leu-Enkephalin
Contraindications
Find Providers
Where to source these peptides
Providers offering
BPC-157
603 listed
Browse directory →
Providers offering
Leu-Enkephalin
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More recovery Comparisons
Browse all peptides →Educational research tools — not medical advice.